0001209191-19-034749.txt : 20190605
0001209191-19-034749.hdr.sgml : 20190605
20190605163351
ACCESSION NUMBER: 0001209191-19-034749
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190603
FILED AS OF DATE: 20190605
DATE AS OF CHANGE: 20190605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ambrogi Michael J.
CENTRAL INDEX KEY: 0001654363
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 19880087
MAIL ADDRESS:
STREET 1: 195 COMMERCE WAY
CITY: PORTSMOUTH
STATE: NH
ZIP: 03801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-03
0
0001645113
NovoCure Ltd
NVCR
0001654363
Ambrogi Michael J.
C/O NOVOCURE INC.
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Operating Officer
Ordinary Shares
2019-06-03
4
M
0
17500
7.15
A
203174
D
Ordinary Shares
2019-06-03
4
S
0
16700
52.094
D
186474
D
Ordinary Shares
2019-06-03
4
S
0
800
52.698
D
185674
D
Ordinary Shares
2019-06-04
4
M
0
17500
7.15
A
203174
D
Ordinary Shares
2019-06-04
4
S
0
17300
53.113
D
185874
D
Ordinary Shares
2019-06-04
4
S
0
200
53.79
D
185674
D
Options to Buy Ordinary Shares
7.15
2019-06-03
4
M
0
17500
0.00
D
2027-02-21
Ordinary Shares
17500
144013
D
Options to Buy Ordinary Shares
7.15
2019-06-04
4
M
0
17500
0.00
D
2027-02-21
Ordinary Shares
17500
126513
D
Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.
On June 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 16,700 shares in multiple trades at prices ranging from $51.64 to $52.63. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On June 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 800 shares in multiple trades at prices ranging from $52.65 to $52.83. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On June 4, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 17,300 shares in multiple trades at prices ranging from $52.73 to $53.70. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On June 4, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 200 shares in multiple trades at prices ranging from $53.74 to $53.84. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Fully vested as of the date hereof.
/s/ Kimberly Burke, Attorney in fact for Michael J. Ambrogi
2019-06-05